Introduction
Cough is one of the most common symptom of many respiratory diseases. Although cough guidelines from various countries are available, there has been no Korean cough guideline. The Korean Academy of Tuberculosis and Respiratory Diseases organized cough guideline committee at March 2013. From March 2013 to October 2014, cough guideline was developed by the members of this committee. The purpose of this guideline is to help clinicians to diagnose correctly and treat efficiently patients with cough. The content of this guideline is confined to adult patients only. This guideline is developed based on evidence. The committee developed key questions and searched evidence in three medical databases, Medline, Embase, Cochrane library and also in three Korean journals, Tuberculosis and Respiratory Diseases, Korean Journal of Medicine, and Allergy, Asthma & Respiratory Disease. The level of evidence was evaluated by the Grading of Recommendations Assessment, Development and Evaluation approach 1 . The strength of recommendation was assigned by formal voting rules from expert committee. The Korean cough guideline is written in Korean and published October 2014. In this article, we have stated recommendation and summary of Korean cough guideline.
Definition, Mechanism, and Epidemiology of Cough

1) Summary
Cough is normal defense mechanism. However, severe or long-standing cough is the most common symptom that results in visit of hospital.
Classification of cough
1) Summary
-Cough can be classified as acute (<3 weeks), subacute (3 to 8 weeks), and chronic (>8 weeks) according to the duration. -Classification of cough according to the duration helps to differentiate cause of cough.
Acute and subacute cough 1) Recommendation
-Beta-2 agonist should not be used to improved cough symptom (evidence, low; recommendation, strong). -Considering adverse effect of antibiotics, empirical therapy of antibiotics can be considered only in patients with purulent sputum (evidence, high; recommendation, weak). 2) Summary -Acute cough can be early symptom of serious diseases such as acute exacerbation of interstitial lung disease (ILD), congestive heart failure, tuberculosis (TB), endobronchial neoplasm, or foreign body aspiration. Thus, these diseases should be included in the differential diagnosis of acute cough (Figures 1, 2 ). -Considering prevalence of TB in Korea, chest X-ray should be checked in patients with acute cough whose duration is more than 2 weeks. -Chest X-ray can be checked in acute cough patients with old age, since symptoms of serious diseases may be nonspecific in them. -For acute cough due to upper respiratory infection (URI), first generation antihistamine is effective 2 , while second generation is not 3, 4 .
-In acute cough due to URI, paranasal sinus X-ray or antibiotics may not be necessary during first 1 week 2,5-7 .
Chronic cough 1) Summary
-Chronic cough is defined as a cough lasting more than 8 weeks. -History including smoking, accompanying symptom, and medication is helpful for differential diagnosis and should be taken first and enough. -Test for upper airway cough syndrome (UACS), cough variant asthma (CVA), and gastroesophageal reflux disease (GERD) should be performed ( Figure 3 ). -Chest X-ray should be performed first [8] [9] [10] . Then, other tests can be performed step by step according to symptom of patient and facilities of hospital.
Upper airway cough syndrome
1) Recommendation -In UACS, intranasal steroid can be considered in order to improve cough (evidence, very low; recommendation, weak). -In UACS, oral anti-histamine is recommended to improve cough (evidence, very low; recommendation, strong). -In UACS, using nasal decongestant only is not recommended to improve cough (evidence, expert opinion; recommendation, strong). -In UACS, intranasal anti-histamine is not considered to improve cough (evidence, very low; recommendation, weak). -In UACS, antibiotics is not recommended to improve cough (evidence, expert opinion; recommendation, strong). 2) Summary -UACS is syndrome of which various upper airway disease cause cough. -UACS is diagnosed based on symptom, physical examination, radiologic finding, and response to empirical treatment. -If UACS is diagnosed, adequate treatment should be initiated.
-If UACS is suspicious, first generation anti-histamine and nasal decongestant can be used empirically.
Cough variant asthma
1) Recommendation -In CVA, leukotriene antagonist (LTRA) can be considered in order to improve cough (evidence, low; recommendation, weak). -In CVA, inhaled corticosteroid (ICS) is recommended in order to improve cough (evidence, expert opinion; recommendation, strong). 11, 12 . -Key medication for EB is ICS.
Gastroesophageal reflux disease
1) Recommendation -In GERD, proton pump inhibitor is recommended in order to improve cough (evidence, low; recommendation, weak). -In GERD, prokinetic is not recommended in order to improve cough (evidence, expert opinion; recommendation, weak).
2) Summary
-If GERD is suspicious as cause of cough, empirical therapy can be performed. -Treatment option for cough due to GERD includes dietotherapy 13, 14 , life style modification [15] [16] [17] [18] [19] , and medication at least 4-8 weeks.
9. Chronic bronchitis 1) Recommendation -In chronic bronchitis (CB) with normal lung function, smoking cessation is recommended in order to improve cough (evidence, expert opinion; recommendation, strong). -In CB with normal lung function, mucoactive agent can be considered in order to improve cough (evidence, expert opinion; recommendation, weak). 23 , theophylline 24 , ICS/long acting beta agonist 25 , and codeine can be used to treat cough in CB with decreased lung function. [27] [28] [29] [30] .
Bronchiectasis
1) Summary -When bronchiectasis is suspicious, high resolution computed tomography (HRCT) is needed even if chest X-ray
Bronchiolitis
1) Recommendation
-In diffuse panbronchiolitis, low-dose macrolide antibiotic is recommended in order to improve cough (evidence, expert opinion; recommendation, strong). 2) Summary -Bronchiolitis should be preferentially considered when there are irreversible airflow obstruction, suspicion of small airway disease in HRCT, and purulent sputum in patients with cough 31 .
Lung cancer 1) Summary
-Chest X-ray should be performed in case of risk factor for lung cancer or metastatic lung cancer. -Bronchoscopy should be performed when suspicious of endobronchial invasion by tumor even if chest X-ray is normal 
Aspiration 1) Summary
-Oropharyngeal dysphagia and aspiration should be checked in case of cough being developed when eating or swallowing food 35 .
14. Angiotensin converting enzyme inhibitor 1) Recommendation -In cough due to angiotensin converting enzyme inhibitor (ACEI), cessation of ACEI is recommended in order to improve cough (evidence, expert opinion; recommendation, strong). 2) Summary -To diagnose cough due to ACEI, detailed history including ACEI administration is needed. -Generally, cough subsides 1-4 weeks after cessation of ACEI. However, cough can last more than 3 months in some patients 36, 37 . 43, 44 . www.e-trd.org
Cough and peritoneal dialysis 1) Summary
-Cough is common symptom in patient with peritoneal dialysis [45] [46] [47] . The cause of cough may be GERD 47, 48 , ACEI, infection 49 , and pulmonary edema.
Cough in immunocompromised patient
1) Summary -The cause of cough in immunocompromised patient is similar with those of immunocompetent. -Opportunistic infection should be included in the differential diagnosis.
Uncommon causes of cough
1) Summary -In the diagnosis of uncommon causes of cough, knowledge of disease, clinical suspicion, and adequate evaluation are very important.
Idiopathic cough 1) Recommendation
-In idiopathic cough, antitussive can be considered in order to improve cough (evidence, expert opinion; recommendation, weak).
2) Summary
-Diagnosis of idiopathic cough should be made when after cough is not improved by adequate therapy and other causes are ruled out 10, 50 .
Treatment agent of cough: antitussive and mucoactive agent 1) Summary
Antitussive is classified as central and peripheral 51, 52 . -Narcotic central antitussive: morphine, codeine -Nonopioid central antitussive: dextromethorphan, levopropoxyphene -Peripheral antitussive: benzonatate, benproperine, theobromine -Etc.: amitriptyline, baclofen, gabapentin Mucoactive agent can be classified as expectorants, mucoregulatory agents, mucolytics, and mucokinetics 53, 54 .
-Expectorants: hypertonic saline, iodinated glycerol, domiodol, guaifenesin, ion channel modifiers -Mucoregulatory agents: carbocysteine, anticholinergics, glucocorticoid, macrolide antibiotics -Mucolytics
• Classic mucolytics: N-acetylcysteine, nacystelyn, bromhexine, erdosteine, fudosteine
• Peptide mucolytics: dornase alfa, gelsolin, thymosin 4
• Nondestructive mucolytics: dextran, heparin -Mucokinetics: inhaled SABA, methylxanthine, surfactant, ambroxol, acebrophylline
